ACTIVE

Apotheek Vijve

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result83,5 k €-20,2 %over 1 year

Gross margin244,4 k €+4,9 %over 1 year

Equity747 k €+6,2 %over 1 year

Workforce1,7 ETP+41,7 %over 1 year

Identity

Source · BCE/KBO

Apotheek Vijve is a Public limited company incorporated in 1989. Its registered office is in Waregem. It employs on average 1,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0439.305.377
Incorporation: 11/12/1989
Legal form: Public limited company
Registered office: Aloise Biebuyckstraat 13
8793 Waregem · FlandreSee on map
Contributed capital: 70 000,00 €
Latest accounts: 31/12/2025
Average workforce: 1,7 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	244,4 k €	+4.9%	232,9 k €	-10.1%	259 k €	+48.0%	175 k €	-2.5%	179,5 k €
EBITDA	125,6 k €	-16.6%	150,6 k €	+7.9%	139,6 k €	+126%	61,7 k €	+22.2%	50,5 k €
Operating result	100,3 k €	-20.4%	126,1 k €	+9.8%	114,9 k €	+149%	46,2 k €	-4.8%	48,5 k €
Net result	83,5 k €	-20.2%	104,6 k €	+1.8%	102,8 k €	+124%	45,9 k €	+23.0%	37,3 k €
Balance sheet
Equity	747 k €	+6.2%	703,4 k €	+10.1%	638,8 k €	+3.7%	616 k €	+6.2%	580,1 k €
Total assets	964,1 k €	+3.0%	936 k €	+0.6%	930,4 k €	+9.4%	850,3 k €	+30.1%	653,4 k €
Cash	246,3 k €	+14.3%	215,6 k €	+49.8%	143,9 k €	-52.0%	299,6 k €	-26.0%	404,6 k €
Debts	217,2 k €	-6.6%	232,5 k €	-20.3%	291,6 k €	+24.5%	234,3 k €	+220%	73,2 k €
Other
Workforce	1,7 ETP	+41.7%	1,2 ETP	-33.3%	1,8 ETP	-5.3%	1,9 ETP	-9.5%	2,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 18 ended

Active mandates

Garju Pharma

bestuurder · since 25 mars 2022 · 0782.512.361

Represented by Stéphanie Goeminne

Active

Ended mandates

Garju Pharma

bestuurder · since 25 mars 2022 · 0782.512.361

Represented by Stéphanie Goeminne

Ended

Garju Pharma

Director · since 25 mars 2022 · 0782.512.361

Represented by Stéphanie Goeminne

Ended

Bart VAN MOERKERKE

Director · since 26 juillet 2017 · until 26 juillet 2017

Ended

Bart VAN MOERKERKE

Director · since 26 juillet 2017 · until 05 mai 2023

Ended

Other companies at this address

Aloise Biebuyckstraat 13 8793 Waregem

Company	CBE no.
Garju Pharma● Active	0782.512.361

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	01/07/2025	12/07/2024	20/07/2023	09/07/2022	25/06/2021
General meeting	27/06/2026	28/06/2025	22/06/2024	24/06/2023	25/06/2022	05/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	27/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	28/06/2025	01/07/2025	Dutch	PDF
Abridged model	31/12/2023	22/06/2024	12/07/2024	Dutch	PDF
Abridged model	31/12/2022	24/06/2023	20/07/2023	Dutch	PDF
Abridged model	31/12/2021	25/06/2022	09/07/2022	Dutch	PDF
Abridged model	31/12/2020	05/05/2021	25/06/2021	Dutch	PDF
Abridged model	31/12/2019	06/05/2020	23/07/2020	Dutch	PDF
Abridged model	31/12/2018	01/05/2019	29/08/2019	Dutch	PDF
Abridged model	31/12/2017	02/05/2018	27/08/2018	Dutch	PDF
Abridged model	31/12/2016	26/07/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	30/07/2016	30/08/2016	Dutch	PDF
Abridged model	31/12/2014	31/07/2015	28/08/2015	Dutch	PDF
Abridged model	31/12/2013	11/08/2014	29/08/2014	Dutch	PDF
Abridged model	31/12/2012	05/06/2013	08/07/2013	Dutch	PDF
Abridged model	31/12/2011	04/07/2012	05/07/2012	Dutch	PDF
Abridged model	31/12/2010	22/06/2011	18/08/2011	Dutch	PDF
Abridged model	31/12/2009	05/05/2010	27/08/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	14/08/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	14/08/2008	Dutch	PDF
Abridged model	31/12/2006	29/06/2007	30/08/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 18 ended

Active mandates

Garju Pharma

bestuurder · since 25 mars 2022 · 0782.512.361

Represented by Stéphanie Goeminne

Active

Ended mandates

Garju Pharma

bestuurder · since 25 mars 2022 · 0782.512.361

Represented by Stéphanie Goeminne

Ended

Garju Pharma

Director · since 25 mars 2022 · 0782.512.361

Represented by Stéphanie Goeminne

Ended

Bart VAN MOERKERKE

Director · since 26 juillet 2017 · until 26 juillet 2017

Ended

Bart VAN MOERKERKE

Director · since 26 juillet 2017 · until 05 mai 2023

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates31/03/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/08/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/11/2011
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/10/2007
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/05/2005
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/12/2004
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202583,5 k €↓
2024
Annual accounts 2024104,6 k €↑
2023
Annual accounts 2023102,8 k €↑
2022
Annual accounts 202245,9 k €↑
2021
Annual accounts 202137,3 k €↑
2021
Name changeApotheek Vijve
2020
Annual accounts 202017,4 k €↑
2019
Annual accounts 201914,6 k €↓
2018
Annual accounts 201830,6 k €↓
2017
Annual accounts 201758,6 k €↑
2016
Annual accounts 201655 k €↓
2015
Annual accounts 201570,6 k €↓
2014
Annual accounts 201491,9 k €↑
2013
Annual accounts 201391,7 k €↑
2012
Annual accounts 201280,8 k €↑
2011
Annual accounts 2011-42,9 k €↓
2010
Annual accounts 2010378,8 k €↑
2009
Annual accounts 200928,7 k €↑
2008
Annual accounts 200819,7 k €↑
2007
Annual accounts 200712,3 k €↑
2006
Annual accounts 20066,5 k €
2006
Name changeVAN MOERKERKE
11/12/1989
IncorporationPublic limited company

Apotheek Vijve

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline